Charles J. Democko
Senior Vice President, Regulatory Affairs and Quality
Mr. Democko joined KaloBios January 2008. Mr. Democko has more than 25 years of experience in research and development in start-up to mid-size pharmaceutical companies. He served as Vice President of Regulatory and Development Operations of Novacea, Inc., a pharmaceutical company, from 2005 to 2008. Prior to Novacea, Mr. Democko served as Vice President, Regulatory Affairs and Development at Signature Therapeutics (previously PharmacoFore, Inc.), a privately-held biopharmaceutical company. Prior to that, he served as Vice President, Regulatory Affairs at Connetics, Inc., a pharmaceutical company acquired by Stiefel Laboratories. Mr. Democko has also held management-level positions at Theravance, Inc., Elan Pharmaceuticals, Inc. and Genentech, Inc., all of which are biopharmaceutical companies. Mr. Democko holds a Bachelor of Science in microbiology from Ohio State University.